The American Bar Association joined the choir of industry groups, former FDA officials, members of Congress and others asking the Supreme Court to keep revisions that have broadened access to a commonly used abortion pill.
While it’s not often that the bar association comments on such cases, the group argued Friday that the Fifth Circuit Court of Appeals was “ill-equipped” to make a decision that would tighten regulations around mifepristone.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.